Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 11.2573 | 99 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 11.0103 | 99 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 10.9773 | 99 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 10.7016 | 98 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 10.9705 | 99 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 11.1924 | 99 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 11.4365 | 99 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 11.0105 | 99 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 11.0185 | 99 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 10.9484 | 99 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 11.2705 | 99 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 11.0409 | 99 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 11.2437 | 99 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 10.9898 | 99 |